Zigakibart

DB18892InvestigationalProtein Based Therapies

Zigakibart is under investigation in clinical trial NCT05852938 (A Study of BION-1301 in Adults With Iga Nephropathy).

Mechanism: Pharmacologically active on Tumor necrosis factor ligand superfamily member 13
Curator reviewed
Code names: BION-1301 · FUB523

Resolves to

Compound

Targets

What you can answer from here — as of June 20, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

7Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Zigakibart, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.